Find your way confidently through the uncertain landscapes that confront pharmaceutical and consumer healthcare companies, with Pinney Associates by your side.
Guiding Pharmaceutical and Consumer Healthcare Companies to Success
We anticipate and help you address scientific and regulatory obstacles, clearing your path to a positive outcome.
Get to know our leaders
“We hold ourselves to the highest standards of excellence in science—guided drug development and regulation to achieve FDA approval with the most appropriate labeling.”
Jack Henningfield, PhD
Vice President, Research, Health Policy, and Abuse Liability
Vice President, Research, Health Policy, and Abuse Liability
“Our clients succeed when they anticipate, and then carefully and thoroughly address, all of the challenges they face—as early in the process as possible.”
Lucy Owen
Senior Vice President
Senior Vice President
“Well-designed behavioral research can resolve key regulatory questions.”
Saul Shiffman, PhD
Senior Scientific Advisor, Behavioral Science, Study Design, and Analysis
Senior Scientific Advisor, Behavioral Science, Study Design, and Analysis
“We work closely with our clients to understand their challenges and determine the best solutions for their specific projects.”
Judy Ashworth, MD
Vice President, Rx Strategic Services and Chief Medical Officer
Vice President, Rx Strategic Services and Chief Medical Officer
Explore our practice areas
Prescription Medicines
Specializing in the development of CNS-active drugs, from traditional pharmaceuticals to psychedelics and cannabinoids
OTC Products
Focusing on Rx-to-OTC switch and support of marketed consumer healthcare brands
Dietary Ingredients & Supplements
Mapping science-based regulatory pathways for dietary ingredients and supplements
Tobacco Harm Reduction
Advancing research and policies that minimize death and disease associated with smoking conventional cigarettes
Get to know our Data Analysis team
We specialize in using data analysis to generate new insights and perspectives, and to answer regulatory and policy questions.